134 related articles for article (PubMed ID: 33512566)
1. Molecular Lymph Node Staging with One-Step Nucleic Acid Amplification and its Prognostic Value for Patients with Colon Cancer: The First Follow-up Study.
Weixler B; Teixeira da Cunha S; Warschkow R; Demartines N; Güller U; Zettl A; Vahrmeijer A; van de Velde CJH; Viehl CT; Zuber M
World J Surg; 2021 May; 45(5):1526-1536. PubMed ID: 33512566
[TBL] [Abstract][Full Text] [Related]
2. Molecular Staging of Patients with Colon Cancer. The C-Closer-II Study: A Multicentre Study in Portugal.
Brito MJ; Honavar M; Cipriano MA; Lopes J; Coelho H; Silva AR; Silva M; Guimarães S; Frutuoso A; Gomes A; Barbosa E; Carlos S
Acta Med Port; 2018 Nov; 31(11):661-669. PubMed ID: 30521460
[TBL] [Abstract][Full Text] [Related]
3. Molecular staging of lymph node-negative colon carcinomas by one-step nucleic acid amplification (OSNA) results in upstaging of a quarter of patients in a prospective, European, multicentre study.
Croner RS; Geppert CI; Bader FG; Nitsche U; Späth C; Rosenberg R; Zettl A; Matias-Guiu X; Tarragona J; Güller U; Stürzl M; Zuber M
Br J Cancer; 2014 May; 110(10):2544-50. PubMed ID: 24722182
[TBL] [Abstract][Full Text] [Related]
4. Molecular investigation of lymph nodes in colon cancer patients using one-step nucleic acid amplification (OSNA): a new road to better staging?
Güller U; Zettl A; Worni M; Langer I; Cabalzar-Wondberg D; Viehl CT; Demartines N; Zuber M
Cancer; 2012 Dec; 118(24):6039-45. PubMed ID: 22684906
[TBL] [Abstract][Full Text] [Related]
5. Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay.
Espinosa-Bravo M; Sansano I; Pérez-Hoyos S; Ramos M; Sancho M; Xercavins J; Rubio IT; Peg V
Eur J Surg Oncol; 2013 Jul; 39(7):766-73. PubMed ID: 23607911
[TBL] [Abstract][Full Text] [Related]
6. A systematic review and economic evaluation of intraoperative tests [RD-100i one-step nucleic acid amplification (OSNA) system and Metasin test] for detecting sentinel lymph node metastases in breast cancer.
Huxley N; Jones-Hughes T; Coelho H; Snowsill T; Cooper C; Meng Y; Hyde C; Mújica-Mota R
Health Technol Assess; 2015 Jan; 19(2):v-xxv, 1-215. PubMed ID: 25586547
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of one-step nucleic acid amplification (OSNA) for sentinel lymph nodes in colon cancer patients.
Vogelaar FJ; Reimers MS; van der Linden RL; van der Linden JC; Smit VT; Lips DJ; van de Velde CJ; Bosscha K
Ann Surg Oncol; 2014 Nov; 21(12):3924-30. PubMed ID: 24912612
[TBL] [Abstract][Full Text] [Related]
8. Clinical application of the one-step nucleic acid amplification method to detect sentinel lymph node metastasis in breast cancer.
Sagara Y; Ohi Y; Matsukata A; Yotsumoto D; Baba S; Tamada S; Sagara Y; Matsuyama Y; Ando M; Rai Y; Sagara Y
Breast Cancer; 2013 Apr; 20(2):181-6. PubMed ID: 22203582
[TBL] [Abstract][Full Text] [Related]
9. Standard ultra-staging compared to one-step nucleic acid amplification for the detection of sentinel lymph node metastasis in endometrial cancer patients: a retrospective cohort comparison.
Fanfani F; Monterossi G; Di Meo ML; La Fera E; Dell'Orto F; Gioè A; Lamanna M; Ferrari D; De Ponti E; Perego P; Restaino S; Carlo R; Zannoni GF; Landoni F; Scambia G; Buda A
Int J Gynecol Cancer; 2020 Mar; 30(3):372-377. PubMed ID: 31996396
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Lymph Node Examination by the OSNA Method in Lung Cancer Patients-Comparison with the Standard Histopathological Procedure.
Vodicka J; Pesta M; Kulda V; Houfkova K; Vankova B; Sebek J; Skala M; Fichtl J; Prochazkova K; Topolcan O
Cells; 2020 Dec; 9(12):. PubMed ID: 33291819
[TBL] [Abstract][Full Text] [Related]
11. One-step nucleic acid amplification (OSNA): where do we go with it?
Tamaki Y
Int J Clin Oncol; 2017 Feb; 22(1):3-10. PubMed ID: 27549784
[TBL] [Abstract][Full Text] [Related]
12. Is it time for one-step nucleic acid amplification (OSNA) in colorectal cancer? A systematic review and meta-analysis.
Wild JB; Iqbal N; Francombe J; Papettas T; Sanders DS; Ramcharan S
Tech Coloproctol; 2017 Sep; 21(9):693-699. PubMed ID: 28887714
[TBL] [Abstract][Full Text] [Related]
13. Detailed evaluation of one step nucleic acid (OSNA) molecular assay for intra-operative diagnosis of sentinel lymph node metastasis and prediction of non-sentinel nodal involvement: experience from a London teaching hospital.
Banerjee SM; Michalopoulos NV; Williams NR; Davidson T; El Sheikh S; McDermott N; Tran-Dang MA; Davison S; Keshtgar MR
Breast; 2014 Aug; 23(4):378-84. PubMed ID: 24630617
[TBL] [Abstract][Full Text] [Related]
14. Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer.
Bizzarri N; Pedone Anchora L; Zannoni GF; Santoro A; Valente M; Inzani F; Gallotta V; Conte C; Chiantera V; Fanfani F; Fagotti A; Ferrandina G; Scambia G
Int J Gynecol Cancer; 2020 Mar; 30(3):364-371. PubMed ID: 31980488
[TBL] [Abstract][Full Text] [Related]
15. Total tumor load assessed by one-step nucleic acid amplification assay as an intraoperative predictor for non-sentinel lymph node metastasis in breast cancer.
Nabais C; Figueiredo J; Lopes P; Martins M; Araújo A
Breast; 2017 Apr; 32():33-36. PubMed ID: 28030783
[TBL] [Abstract][Full Text] [Related]
16. A new diagnostic method for rapid detection of lymph node metastases using a one-step nucleic acid amplification (OSNA) assay in endometrial cancer.
Nagai T; Niikura H; Okamoto S; Nakabayashi K; Matoda M; Utsunomiya H; Nagase S; Watanabe M; Takeshima N; Yaegashi N
Ann Surg Oncol; 2015 Mar; 22(3):980-6. PubMed ID: 25190122
[TBL] [Abstract][Full Text] [Related]
17. Sentinel node tumour burden quantified based on cytokeratin 19 mRNA copy number predicts non-sentinel node metastases in breast cancer: molecular whole-node analysis of all removed nodes.
Osako T; Iwase T; Kimura K; Horii R; Akiyama F
Eur J Cancer; 2013 Apr; 49(6):1187-95. PubMed ID: 23265708
[TBL] [Abstract][Full Text] [Related]
18. A differential intra-operative molecular biological test for the detection of sentinel lymph node metastases in breast carcinoma. An extended experience from the first U.K. centre routinely offering the service in clinical practice.
Babar M; Madani R; Thwaites L; Jackson PA; Devalia HL; Chakravorty A; Irvine TE; Layer GT; Kissin MW
Eur J Surg Oncol; 2014 Mar; 40(3):282-8. PubMed ID: 24331309
[TBL] [Abstract][Full Text] [Related]
19. Validation of prognostic and predictive value of total tumoral load after primary systemic therapy in breast cancer using OSNA assay.
Bernet-Vegué L; Cantero-González C; Sancho de Salas M; Parada D; Perin T; Quintero-Niño Z; Vieites Pérez-Quintela B; Sánchez-Guzmán D; Castelvetere M; Hardisson Hernaez D; Martín-Salvago MD
Clin Transl Oncol; 2024 May; 26(5):1220-1228. PubMed ID: 38070048
[TBL] [Abstract][Full Text] [Related]
20. Triple assessment of sentinel lymph node metastasis in early breast cancer using preoperative CTLG, intraoperative fluorescence navigation and OSNA.
Mokhtar M; Tadokoro Y; Nakagawa M; Morimoto M; Takechi H; Kondo K; Tangoku A
Breast Cancer; 2016 Mar; 23(2):202-10. PubMed ID: 25069434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
